NEW YORK, NY–(Marketwired – Feb 27, 2017) – Rising India Inc. ( OTC : RSII ) has received several requests from shareholders for a recap to the Company’s Shareholder Conference call which featured detailed information about the incoming merger company, Rising Biosciences, Inc.
Rising BioSciences, Inc. will be a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry. Aside from cancer treatment and pain management, some of the uses for medical marijuana include treatment of conditions such as seizure disorders, multiple sclerosis, Parkinson’s disease, rheumatoid arthritis, glaucoma and Crohn’s disease.
Rising Biosciences is comprised of a team of chemists, physicians, pharmacists and medical marijuana industry veterans for the development of products in a clinical lab environment. Operations will focus on creating product that can